hyaluronidase-lpuj 2000 UNT/ML
RxNorm concept 2729291, clinical drug component (scdc).
- RxCUI
- 2729291
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2729291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- 10 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection (SCD, constitutes)
- 10 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection [Rybrevant Faspro] (SBD, constitutes)
- 14 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection (SCD, constitutes)
- 14 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection [Rybrevant Faspro] (SBD, constitutes)
- 15 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection (SCD, constitutes)
- 15 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection [Rybrevant Faspro] (SBD, constitutes)
- 22 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection (SCD, constitutes)
- 22 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection [Rybrevant Faspro] (SBD, constitutes)
- hyaluronidase (IN, has ingredient)
- hyaluronidase-lpuj (PIN, has precise ingredient)
- amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML [Rybrevant Faspro] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2729291 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2729291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2729291. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.